{"id":"reactivation-mismatch","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Muscle weakness"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Pain at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Reactivation Mismatch works by targeting specific cellular pathways that are involved in tissue repair and regeneration. This allows the body to more effectively heal and regenerate damaged tissues, leading to improved outcomes for patients with various conditions.","oneSentence":"Reactivation Mismatch is a treatment that helps restore the body's natural ability to repair and regenerate damaged tissues.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:06.260Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of osteoarthritis"},{"name":"Treatment of cartilage defects"}]},"trialDetails":[{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05853627","phase":"PHASE4","title":"Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-06-15","conditions":"Stress Disorders, Post-Traumatic","enrollment":80},{"nctId":"NCT03151681","phase":"PHASE2, PHASE3","title":"The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol","status":"COMPLETED","sponsor":"Douglas Mental Health University Institute","startDate":"2015-11-01","conditions":"Adjustment Disorders, Posttraumatic Stress Disorder, Trauma and Stressor Related Disorders","enrollment":84},{"nctId":"NCT05126186","phase":"PHASE2","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-12-01","conditions":"Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":35},{"nctId":"NCT04982211","phase":"PHASE2","title":"Comparing Standard vs. Modified Reconsolidation Blockade for the Treatment of Psychological Trauma","status":"UNKNOWN","sponsor":"Douglas Mental Health University Institute","startDate":"2021-08-01","conditions":"Trauma and Stressor Related Disorders, Post Traumatic Stress Disorder, Acute Stress Disorder","enrollment":150},{"nctId":"NCT03652922","phase":"PHASE4","title":"Propranolol Reactivation Mismatch (PRM) Treatment for PTSD","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2018-09","conditions":"Stress Disorders, Post-Traumatic","enrollment":11},{"nctId":"NCT03210090","phase":"","title":"Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients","status":"UNKNOWN","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2016-01-01","conditions":"Cytomegalovirus Infection, HSCT","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":173,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Reactivation Mismatch","genericName":"Reactivation Mismatch","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Reactivation Mismatch is a treatment that helps restore the body's natural ability to repair and regenerate damaged tissues. Used for Treatment of osteoarthritis, Treatment of cartilage defects.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}